Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Agile Therapeutics secures funds to advance AG-200-15 and AG-1000

June 15, 2010

Takeda receives pricing approval for Nesina in Japan

June 15, 2010

Merck KGaA identifies new series of Sgk1 inhibitors

June 15, 2010

FDA lifts clinical hold on Repros Therapeutics' Proellex

June 14, 2010

MannKind's Afrezza noninferior to lispro in type 1 diabetes

June 14, 2010

Rilonacept meets primary endpoint in Regeneron's phase III trial in gout

June 11, 2010

Columbia Labs completes enrollment in phase III Prochieve trial

June 10, 2010

TransTech and Forest enter into agreement to develop GKAs

June 10, 2010

Merck & Co. presents new sst5 receptor antagonists

June 10, 2010

Merck & Co. claims new cholesterol absorption inhibitors

June 10, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...